Human Genome Epidemiology Literature Finder
Records 1 - 11 (of 11 Records) |
Query Trace: Body Weight and EGFR[original query] |
---|
Erlotinib in African Americans with advanced non-small cell lung cancer: a prospective randomized study with genetic and pharmacokinetic analyses. Clinical pharmacology and therapeutics 2014 Aug 96 (2): 182-91. Phelps M A, Stinchcombe T E, Blachly J S, Zhao W, Schaaf L J, Starrett S L, Wei L, Poi M, Wang D, Papp A, Aimiuwu J, Gao Y, Li J, Otterson G A, Hicks W J, Socinski M A, Villalona-Calero M |
Influence of ABCC2 and ABCC4 polymorphisms on tenofovir plasma concentrations in Thai HIV-infected patients. Antimicrobial agents and chemotherapy 2015 Jun 59 (6): 3240-5. Rungtivasuwan Kanokrat, Avihingsanon Anchalee, Thammajaruk Narukjaporn, Mitruk Siwaporn, Burger David M, Ruxrungtham Kiat, Punyawudho Baralee, Pengsuparp Thiti |
Genetic and environmental predictors of chronic kidney disease in patients with type 2 diabetes and diabetic foot ulcer: a pilot study. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2015 Oct 66 (5): 751-61. Mrozikiewicz-Rakowska B, Maroszek P, Nehring P, Sobczyk-Kopciol A, Krzyzewska M, Kaszuba A M, Lukawska M, Chojnowska N, Kozka M, Bujalska-Zadrozny M, Ploski R, Krzymien J, Czupryniak |
Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer. Cancer chemotherapy and pharmacology 2017 03 79 (3): 497-505. Imai Hisao, Kuwako Tomohito, Kaira Kyoichi, Masuda Tomomi, Miura Yosuke, Seki Kaori, Sakurai Reiko, Utsugi Mitsuyoshi, Shimizu Kimihiro, Sunaga Noriaki, Tomizawa Yoshio, Ishihara Shinichi, Ishizuka Takao, Mogi Akira, Hisada Takeshi, Minato Koichi, Takise Atsushi, Saito Ryusei, Yamada Masano |
Factors affecting time to reach and recover from gefitinib-induced hepatotoxicity. Anti-cancer drugs 2018 3 29 (5): 471-476. Park Yoon Hee, Cho Soyeon, Yee Jeong, Kim Jae Youn, Rhie Sandy Jeong, Gwak Hye S |
Risk factors for erlotinib-induced hepatotoxicity: a retrospective follow-up study. BMC cancer 2018 10 18 (1): 988. Kim Min Kyoung, Yee Jeong, Cho Yoon Sook, Jang Hong Won, Han Ji Min, Gwak Hye S |
Circulating total and intact GDF-15 levels are not altered in response to weight loss induced by liraglutide or lorcaserin treatment in humans with obesity. Metabolism: clinical and experimental 2022 Jun 133 155237. Valenzuela-Vallejo Laura, Chrysafi Pavlina, Bello-Ramos Jenny, Bsata Shahd, Mantzoros Christos |
Population pharmacokinetics of oxcarbazepine active metabolite in Chinese children with epilepsy. European journal of pediatrics 2023 7 . Xingmeng Li, Shifeng Wei, Han Wu, Qiang Zhang, Zhigang Zhao, Shenghui Mei, Weixing Feng, Yun |
Effects of single nucleotide polymorphisms of the folylpolyglutamate synthase gene on pemetrexed administration-induced nephropathy. British journal of clinical pharmacology 2023 7 . Yuki Mitarai, Ryosuke Tanino, Kazuhisa Nakashima, Takamasa Hotta, Takeshi Isobe, Yukari Tsuba |
Pharmacokinetic and dose-finding study of osimertinib in patients with impaired renal function and low body weight. Cancer science 2023 1 . Fujiwara Yutaka, Makihara Reiko, Hase Tetsunari, Hashimoto Naozumi, Naito Tomoyuki, Tsubata Yukari, Okuno Takae, Takahashi Toshiaki, Kobayashi Haruki, Shinno Yuki, Zenke Yoshitaka, Ikeda Takaya, Hosomi Yukio, Watanabe Kageaki, Kitazono Satoru, Sakiyama Naomi, Makino Yoshinori, Yamamoto Nobo |
Relationship Between Osimertinib Concentration and Clinical Response in Japanese Patients With Non-small Cell Lung Cancer. Anticancer research 2023 1 43 (2): 725-732. Yamazaki Mizuki, Komizo Nao, Iihara Hirotoshi, Hirose Chiemi, Yanase Komei, Yamada Yuto, Endo Junki, Yamashita Shuji, Ohno Yasushi, Todoroki Kenichiro, Suzuki Akio, Hayashi Hide |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: